Post-transaction, Tan will still have a residual direct interest of 0.40% and a deemed interest of 1.37% in TMC other than through the BCorp Group. (Inset: Peter Lim Eng Hock: Crosses mandatory takeover threshold. - AFPpic)
PETALING JAYA: Singapore billionaire Peter Lim Eng Hock has acquired an additional 26.6% in TMC Life Sciences Bhd
from Tan Sri Vincent Tan Chee Yioun for 48 sen per share, raising his stake in the company to 59.2% and triggering a general offer for the rest of the shares he does not already own in the process.
Lim, however, intends to maintain the healthcare provider’s listing status on Bursa Malaysia.
Already a subscriber? Log in
The Star Festive Promo: Get 35% OFF Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
